ArticleTherapeutic advances in gastroenterology2017

Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma.

Beom Su Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.